A Study of Biological Markers for the Nervous and Immune Systems and Free Radical Mediated Processes in Amyotrophic Lateral Sclerosis (ALS)

Investigator: Stanley Appel, MD

Study Coordinator: Aramide Balogun

Status: Enrolling

ClinicalTrials.gov Number: NCT99999999

Phone: 713.441.6937

Protocol Number: PRO00026718


The purpose of this protocol is to develop and maintain a biospecimen bank comprised of blood, urine, CSF collected during diagnostic evaluations, tissue from biopsies and autopsies collected from patients with neurological disease and non-neurologically affected age-matched volunteers.
More to Explore